Modeling "psychosis" in vitro by inducing disordered neuronal network activity in cortical brain slices.
about
Investigating the mechanisms of hallucinogen-induced visions using 3,4-methylenedioxyamphetamine (MDA): a randomized controlled trial in humansMetabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonistsIdentification of three residues essential for 5-hydroxytryptamine 2A-metabotropic glutamate 2 (5-HT2A·mGlu2) receptor heteromerization and its psychoactive behavioral functionPreclinical models of antipsychotic drug action.Preclinical evaluation of the antipsychotic potential of the mGlu2-positive allosteric modulator JNJ-40411813.Animal models of serotonergic psychedelics.Auditory steady state responses in a schizophrenia rat model probed by excitatory/inhibitory receptor manipulation.HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity.Glutamatergic model psychoses: prediction error, learning, and inferenceRapid neocortical dynamics: cellular and network mechanisms.Functional selectivity in GPCR heterocomplexes.Psychedelics Recruit Multiple Cellular Types and Produce Complex Transcriptional Responses Within the Brain.Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways.Tonic neuromodulation of the inspiratory rhythm generator.Interactions of Hallucinogens with the Glutamatergic System: Permissive Network Effects Mediated Through Cortical Layer V Pyramidal Neurons.Serotonergic Hallucinogen-Induced Visual Perceptual Alterations.GLYX-13 Produces Rapid Antidepressant Responses with Key Synaptic and Behavioral Effects Distinct from Ketamine.β2-Adrenergic Receptor Activation Suppresses the Rat Phenethylamine Hallucinogen-Induced Head Twitch Response: Hallucinogen-Induced Excitatory Post-synaptic Potentials as a Potential Substrate.
P2860
Q21091087-D742800B-0516-490D-B809-799A14F42C06Q22251267-C9F528FC-5328-4067-8C0A-C85CFE53C52CQ24594672-BA1A66D9-8DF3-4F9A-83BE-7AB236635143Q26827502-071F890E-B925-47F8-8944-5696A3A6A74BQ30418647-D174DBA1-8D0A-43BB-91E5-D45B45946B42Q30444312-BCB898D8-FBEE-41FA-AA44-2AD4B80B44D1Q30447745-BE87EBF3-B2A5-40DA-B7AA-2FED9C63751FQ30457800-707026EE-2D1C-463F-BB89-8A122AD6E5A6Q34661231-508D0D50-993A-4851-9185-9807C07619D6Q37466841-6C2973E7-B38D-4218-BAE8-DF5537773A28Q38017279-75BC16DC-71C9-4A1F-BB26-12094DC2CC0FQ39370168-105DCA51-0420-4D76-8903-73066893FEA5Q39414464-2321A160-9538-44D2-9CD3-785FBD89449FQ42321516-7C06FCA5-4A97-4EA6-9360-48E852166995Q48143733-FAEAE7CD-4E82-4826-B205-D7A2031F0099Q48412295-056009B2-A2E5-4F9F-B8AB-7008935C98C4Q48472517-5C75ECA6-001B-4AD3-8A83-C9ED18C67D4CQ50191924-51336E6E-547B-4437-AB19-0C237B1EED42
P2860
Modeling "psychosis" in vitro by inducing disordered neuronal network activity in cortical brain slices.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Modeling "psychosis" in vitro ...... vity in cortical brain slices.
@en
Modeling "psychosis" in vitro ...... vity in cortical brain slices.
@nl
type
label
Modeling "psychosis" in vitro ...... vity in cortical brain slices.
@en
Modeling "psychosis" in vitro ...... vity in cortical brain slices.
@nl
prefLabel
Modeling "psychosis" in vitro ...... vity in cortical brain slices.
@en
Modeling "psychosis" in vitro ...... vity in cortical brain slices.
@nl
P2860
P921
P1433
P1476
Modeling "psychosis" in vitro ...... vity in cortical brain slices.
@en
P2093
George K Aghajanian
P2860
P2888
P304
P356
10.1007/S00213-009-1484-9
P577
2009-02-25T00:00:00Z
2009-11-01T00:00:00Z